Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2010
08/24/2010US7781566 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
08/24/2010US7781414 Targets for tumor growth inhibition
08/24/2010US7781397 Immunoaffinity purification
08/24/2010US7781395 Process for purifying proteins
08/24/2010US7781219 Risk markers for cardiovascular disease
08/24/2010US7781212 Antibody which binds fetal thymocytes, inhibitits cell proliferation and does not bind adult thymocytes; for use in treatment and prevention of cell proliferative disorders; immunotherapy
08/24/2010US7781201 have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or high-glucose syrup or a mixed syrup, and for liquifying a starch-comprising composition
08/24/2010US7781198 Nucleotide sequences coding enzymatic polypeptide for use as amplification tool in genetic engineering
08/24/2010US7781181 Human T1R2 polypeptide functional assays
08/24/2010US7781176 Antibodies to HTEEB42 protein
08/24/2010US7781168 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
08/24/2010US7780964 Immunoglobulins which bind NOGO
08/24/2010US7780963 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases
08/24/2010US7780962 Insertion of viruse genes into cells; administering interferon sensitivity Rna virus; antitumor agents, anticancer agents
08/24/2010US7780959 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2448788C Methods for purifying highly anionic proteins
08/24/2010CA2181924C Diagnosis and treatment of infections due to streptococci and enterococci
08/19/2010WO2010093814A1 Methods of treating dementia using a gm-csf antagonist
08/19/2010WO2010093801A1 Antibody to cytolethal distending toxin of campylobacter jejuni
08/19/2010WO2010093467A1 Methods for inducing transplantation tolerance
08/19/2010WO2010093335A1 Antibodies for diagnosis and treatment of flaviviral infections
08/19/2010WO2010093214A2 Monoclonal antibody recognizing scye1 and use thereof
08/19/2010WO2010093055A1 Anti-mst1r antibodies and uses thereof
08/19/2010WO2010092943A1 IgG-Fc FRAGMENT AND PROCESS FOR PRODUCING SAME
08/19/2010WO2010092335A1 Method for producing protein
08/19/2010WO2010073247A3 Egfr-homing double-stranded rna vector for systemic cancer treatment
08/19/2010WO2010073012A3 Human anti tshr antibodies
08/19/2010WO2010067308A3 Tmem154 polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
08/19/2010WO2010066803A3 Human antibodies against human tissue factor
08/19/2010WO2010056816A3 βGI-IGG INTRON FOR ENHANCED ANTI-IGF1 R EXPRESSION
08/19/2010WO2010048304A3 Identification of signature genes associated with hepatocellular carcinoma
08/19/2010WO2010042904A3 Tcr complex immunotherapeutics
08/19/2010WO2010041892A3 Novel application of aimp1 polypeptide
08/19/2010WO2010040572A3 Antibodies against h5n1 influenza viruses
08/19/2010WO2010030641A3 Pancreatic cancer markers
08/19/2010WO2010025369A3 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases
08/19/2010WO2009109908A8 Methods of treating inflammatory pain
08/19/2010US20100212037 Mia-2 protein
08/19/2010US20100212035 Compositions and Methods for Producing Transgenic Mammals Having Recombinant Immunoglobulin Loci
08/19/2010US20100212033 Novel ubiquitin lifases as therapeutic tragets
08/19/2010US20100212029 Novel assays utilizing nicotinic acetylcholine receptor subunits
08/19/2010US20100211066 Use of IMP3 as a Prognostic Marker for Cancer
08/19/2010US20100210831 Immunocytokine Sequences and Uses Thereof
08/19/2010US20100210825 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
08/19/2010US20100210824 Method of Identifying Drugs, Targeting Moieties or Diagnostics
08/19/2010US20100210823 Method of Preparing Enriched Antibodies for Detecting Mycobacterial Infection
08/19/2010US20100210821 Process for isolation and purification of a target protein free of prion protein (prpsc)
08/19/2010US20100210816 NMDAR Biomarkers for Diagnosing and Treating Cerebral Ischemia
08/19/2010US20100210039 Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein
08/19/2010US20100210034 Methods of determining patient response by measurement of her-3
08/19/2010US20100209962 Tetranor PGDM: A Biomarker of PGD2 Synthesis In Vivo
08/19/2010US20100209956 Methods and compositions for modulating hepatocyte growth factor activation
08/19/2010US20100209946 Uses of water-dispersible silica nanoparticles for attaching biomolecules
08/19/2010US20100209939 Bnp(1-32) epitope and antibodies directed against said epitope
08/19/2010US20100209907 Isolated mammalian monocyte cell genes; related reagents
08/19/2010US20100209905 Protein d - an igd-binding protein of haemophilus influenzae
08/19/2010US20100209904 Antibodies for oncogenic strains of HPV and methods of their use
08/19/2010US20100209490 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209457 Pneumococcal serotype 6d
08/19/2010US20100209446 Ostertagia Vaccine
08/19/2010US20100209441 Drug for suppressing pathogen occurring in vivo
08/19/2010US20100209439 Anti-Prominin-1 Antibody having ADCC Activity or CDC Activity
08/19/2010US20100209438 OVR110 Antibody Compositions and Methods of Use
08/19/2010US20100209436 Method for treating diseases related to mitochondrial dysfunction
08/19/2010US20100209435 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
08/19/2010US20100209434 Antibody formulation
08/19/2010US20100209432 Monoclonal antibodies against glypican-3
08/19/2010US20100209430 Method for treating erectile dysfunction
08/19/2010US20100209429 Peptides and methods for the treatment of gliomas and other cancers
08/19/2010US20100209428 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15
08/19/2010US20100209427 Lysine acetylation sites
08/19/2010US20100209426 Inhibitors of progastrin-induced repression of icat for treating and/or preventing colorectal cancer, adenomatous polyposis or metastasis displaying progastrin-secreting cells and cells in which the beta-catenin/tcf-mediated transcriptional pathway is constitutively active
08/19/2010US20100209425 Blood-Brain Barrier Targeting Anti-bodies
08/19/2010US20100209424 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof
08/19/2010US20100209423 Contain an Fc part derived from human origin and do not bind complement factor C1q; for inflammatory and thrombotic disorders such as critical limb ischemia or peripheral arterial occlusive disease; atherosclerosis, thrombosis, restenosis, asthma, arthritis
08/19/2010US20100209422 Antibodies specific for the protofibril form of beta-amyloid protein
08/19/2010US20100209417 Antibody Treatment of Alzheimer's and Related Diseases
08/19/2010US20100209416 Immunoassays for lamotrigine
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209352 Synthesis and conjugation of iron oxide nanoparticles to antibodies for targeting specific cells using fluorescence and mr imaging techniques
08/19/2010US20100209346 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
08/19/2010US20100209342 Apcdd1 inhibitors for treating, diagnosing or detecting cancer
08/19/2010US20100209341 Treatment of chronic inflammatory conditions
08/19/2010CA2752136A1 Anti-mst1r antibodies and uses thereof
08/19/2010CA2752033A1 Antibody to cytolethal distending toxin of campylobacter jejuni
08/19/2010CA2749501A1 Immunoconjugates with an intracellularly-cleavable linkage
08/19/2010CA2726230A1 The stabilisation of proteins
08/18/2010EP2218782A2 Anti-OX40L Antibodies
08/18/2010EP2218737A2 Humanized anti-NGF antibodies
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218733A1 Compounds and methods for treatment and diagnosis of chlamydial infection
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218461A1 CD40 antibody formulation and methods
08/18/2010EP2217626A1 Epitope for neutralizing antibodies
08/18/2010EP2217625A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
08/18/2010EP2217624A1 Immunoglobulin aggregates
1 ... 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 ... 1494